Edwards Lifesciences Corporation

NYSE:EW

Medical - Devices

Healthcare
$105.23 +0.57%

+$0.49 today

Market cap
$60.51B
Beta
0.87
P/E (TTM)
46.2
EPS (TTM)
$1.89
52W Low $72.30High $89.60

Volume 3.92M

Average 5.02M

EW Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

Edwards Lifesciences CorporationNYSE: EW

Common Stock · Q2 FY2026 · quarter ended Jun 2026

Common stock broadly unchanged from a year ago

Common stock stood at $661.7M at the end of Q2 FY2026, up 0.6% from a year earlier and up 0.3% from the prior quarter. Over 3 fiscal years it compounded at +0.6% a year.

Context

  • Common stock amounted to 4.8% of total assets at the end of Q2 FY2026, down 0.1 pp from a year earlier.
  • Common stock increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps rising in the next quarterly balance sheet after a +0.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$661.7M+0.3% QoQ
Last fiscal yearDec 2025
$658.7M+0.6% YoY
Year agoJun 2025
$657.6M+0.6% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.6%——
1 year+0.6%——
3-year CAGR+0.6%——
5-year CAGR——
10-year CAGR——

Common Stock history

USD · from the balance sheet

Latest · FY2025
658.7M USD
Year-over-year change
+0.6%
4-year CAGR
+0.6%

Common Stock vs competitors

How EW compares with its peers on the latest reported figures

  • EW's Jun 2026 common stock of $661.7M is the highest of the 6 companies compared; the peer median is $39K.
  • Its year-over-year change of +0.6% is the 3rd highest of 6, against a peer median of +0.0%.
  • Common stock amounts to 4.8% of total assets for EW, versus a peer median of 0.0%.
EW Competitors Peer median
Common Stock for EW and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
EWEdwards Lifesciences CorporationJun 2026$661.7M +0.6%+0.6%4.8%
AORTArtivion, Inc.Mar 2026$500K +13.1%+5.7%0.1%
ISRGIntuitive Surgical, Inc.Sep 2026$300K -25.0%+0.0%0.0%
PENPenumbra, Inc.Jun 2026$39K +0.0%+0.9%0.0%
AVRAnteris Technologies Global Corp.Mar 2026$10K +150.0%-97.1%0.0%
LIVNLivaNova PLCSep 2026$0 -100.0%—0.0%
Peer median (excluding EW) $39K+0.0%+0.4%0.0%

Competitors are the stored peer set for EW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents862.8M769M1.13B3.05B2.94B
Short-term Investments604M446.3M500.5M930.7M1.29B
Net Receivables664.9M699.1M828.1M727.4M912.1M
Inventory726.7M875.5M903.5M1.09B1.13B
Other Current Assets237.1M195.9M542.5M374.4M338.8M
Total Current Assets3.18B3.1B4.04B6.29B6.74B
Property, Plant & Equipment (Net)1.64B1.73B1.68B1.78B1.91B
Goodwill1.17B1.16B1.15B1.78B1.77B
Intangible Assets323.6M285.2M399.4M1.18B1.13B
Long-term Investments1.83B1.24B583.9M307.9M773.9M
Tax Assets246.7M484M749.4M992.1M1.14B
Other Non-current Assets110.8M299.1M774.3M732.4M234.9M
Total Non-current Assets5.32B5.2B5.33B6.77B6.96B
Total Assets8.5B8.29B9.36B13.06B13.7B
Account Payables204.5M201.9M186.6M197.4M227.5M
Short-term Debt000024.5M
Tax Payables99.5M96.2M106.5M374.7M0
Deferred Revenue00053.7M27.2M
Other Current Liabilities342.7M305M530.2M442.7M874.5M
Total Current Liabilities1.03B1.02B1.2B1.51B1.81B
Long-term Debt595.7M596.3M597M597.7M598.3M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities969.6M797.6M786.2M810.6M865M
Total Non-current Liabilities1.63B1.46B1.45B1.49B1.55B
Total Liabilities2.67B2.49B2.64B2.99B3.36B
Common Stock642M646.3M650.5M654.8M658.7M
Retained Earnings6.07B7.59B8.99B13.17B14.24B
Accumulated OCI(157.7M)(254.9M)(242.8M)(244.5M)(238.3M)
Other Stockholders Equity00000
Minority Interest0069.4M64.5M0
Total Equity5.84B5.81B6.72B10.06B10.34B
Total Debt690.3M691.3M685.1M700M705.4M
Net Debt(172.5M)(77.7M)(447.2M)(2.35B)(2.23B)

Edwards Lifesciences Corporation

NYSE:EW

Intrinsic Alpha fair value

Locked

Current Price

$105.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.